Welcome to our dedicated page for MAXLINEAR SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MAXLINEAR's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MAXLINEAR's regulatory disclosures and financial reporting.
MaxLinear, Inc. filed a current report to let investors know it has released its unaudited financial results for the fourth quarter and full year ended December 31, 2025. The company issued a press release on January 29, 2026, which is attached as an exhibit.
The press release is furnished as Exhibit 99.1 and provides the detailed quarterly and annual financial information, while the report itself clarifies that this information is not deemed filed for liability purposes under certain securities laws.
MaxLinear, Inc. reported that its board of directors has approved a share repurchase program authorizing the buyback of up to $75 million of its common stock through November 20, 2028. Repurchases may be made in the open market, through block trades, or via privately negotiated transactions, including under Rule 10b5-1 trading plans, in compliance with Rule 10b-18. The program is discretionary, does not require the company to repurchase any shares, and can be modified, suspended, or terminated at any time based on factors such as liquidity, share price, market conditions, and legal requirements.
MaxLinear, Inc. (MXL) reported insider transactions by a director. On 10/29/2025, the director sold 9,055 shares of common stock at $15.8693. On 10/30/2025, the director sold 20,747 shares at a $15.3928 weighted-average price, with underlying trades between $15.39 and $15.415. Following these sales, the director held 12,141 shares directly.
MaxLinear, Inc. (MXL) reported Q3 2025 results showing higher sales and narrower losses. Net revenue reached $126.5 million versus $81.1 million a year ago, lifting gross profit to $71.9 million. Operating expenses were $113.2 million, including $11.3 million in restructuring charges, resulting in a loss from operations of $41.3 million. Net loss improved to $45.5 million (basic and diluted EPS $(0.52)) from $75.8 million (EPS $(0.90)$) in Q3 2024.
For the nine months, revenue was $331.2 million with a net loss of $121.8 million. Cash, cash equivalents and restricted cash totaled $113.3 million at quarter‑end, alongside $125.0 million of term debt maturing in 2028 (weighted average effective rate ~7.0%). Operating cash flow turned positive at $9.2 million year‑to‑date, aided by working capital movements. Stockholders’ equity was $464.7 million. As of October 15, 2025, MaxLinear had 87,372,834 common shares outstanding.
MaxLinear, Inc. filed an 8-K to report that it issued a press release announcing its unaudited financial results for the third quarter ended September 30, 2025. The press release is furnished as Exhibit 99.1 and incorporated by reference.
The company states the information is being furnished under Item 2.02 and shall not be deemed filed for purposes of Section 18 of the Exchange Act. It will only be incorporated by reference in other filings if expressly set forth. The filing also lists the Cover Page Interactive Data File as Exhibit 104.
Greg Dougherty, a director of MaxLinear, Inc. (MXL), amended his Form 4 to report an award of 15,741 restricted stock units (RSUs) granted with a transaction date of 05/20/2025. Each RSU converts to one share of common stock and the award was reported at a price of $0 because RSUs are not purchased. The amendment corrects the number of RSUs previously reported on 05/22/2025. The RSUs vest 100% on the earlier of 05/01/2026 or the date immediately preceding the next annual meeting of stockholders, provided the reporting person remains a director. Following the award, the reporting person beneficially owns 15,741 shares directly.
MaxLinear, Inc. (MXL) filed an amended Form 4 disclosing a grant of 15,741 restricted stock units (RSUs) to director Albert J. Moyer. The RSUs were granted on 05/20/2025 and each RSU represents a contingent right to one share of common stock. The amendment corrects the number of RSUs reported in the initial Form 4 filed 05/22/2025. The RSUs vest 100% on the earlier of 05/01/2026 or the date immediately preceding the next annual meeting of stockholders, provided the reporting person continues as a director. Following the award, Mr. Moyer beneficially owns 15,741 shares directly.
MaxLinear, Inc. director Carolyn Beaver amended her Form 4 to report the grant of 15,741 restricted stock units (RSUs) on 05/20/2025. Each RSU converts into one share of common stock and the award was reported with an exercise/price of $0, indicating a time‑based compensation award rather than a purchase. The amendment corrects the previously reported RSU count from the Form 4 filed 05/22/2025. Vesting is contingent on continued service as a director: 100% of the RSUs vest on the earlier of 05/01/2026 or the day before the next annual meeting of stockholders.
Thomas E. Pardun, a director of MaxLinear, Inc. (MXL), amended a Form 4 to report an award of 15,741 restricted stock units (RSUs) granted on 05/20/2025. Each RSU converts to one share of common stock and was reported with a zero grant price.
The RSUs vest 100% on the earlier of 05/01/2026 or the day immediately before the next annual meeting of stockholders, provided the reporting person remains a director. Following the reported transaction the reporting person beneficially owns 15,741 shares directly. The amendment corrects the number of RSUs previously reported on 05/22/2025.
MaxLinear, Inc. director Daniel A. Artusi amended a Form 4 to report receipt of 15,741 restricted stock units (RSUs) granted on 05/20/2025. Each RSU converts to one share of common stock on vesting. The amendment corrects the originally reported RSU count from the Form 4 filed 05/22/2025. The award vests 100% on the earlier of 05/01/2026 or immediately before the next annual meeting, but only if the reporting person remains a director through that date. Following the grant, Mr. Artusi beneficially owns 15,741 shares represented by these RSUs, held directly and reported at a price of $0 per unit (no cash purchase). The filing is dated and signed by an attorney-in-fact on 10/10/2025.